CN1168634A - 用于骨质疏松症疗程的试剂盒 - Google Patents

用于骨质疏松症疗程的试剂盒 Download PDF

Info

Publication number
CN1168634A
CN1168634A CN95196670A CN95196670A CN1168634A CN 1168634 A CN1168634 A CN 1168634A CN 95196670 A CN95196670 A CN 95196670A CN 95196670 A CN95196670 A CN 95196670A CN 1168634 A CN1168634 A CN 1168634A
Authority
CN
China
Prior art keywords
shandong
tall
erect
test kit
supplementary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95196670A
Other languages
English (en)
Chinese (zh)
Inventor
M·加萨德
O·格罗斯
J·吉拉德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of CN1168634A publication Critical patent/CN1168634A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN95196670A 1994-12-06 1995-12-05 用于骨质疏松症疗程的试剂盒 Pending CN1168634A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94/14630 1994-12-06
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
CN1168634A true CN1168634A (zh) 1997-12-24

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95196670A Pending CN1168634A (zh) 1994-12-06 1995-12-05 用于骨质疏松症疗程的试剂盒

Country Status (20)

Country Link
EP (1) EP0797444A1 (fr)
JP (1) JPH10509729A (fr)
KR (1) KR980700083A (fr)
CN (1) CN1168634A (fr)
AR (1) AR002946A1 (fr)
AU (1) AU4307396A (fr)
BR (1) BR9509961A (fr)
CA (1) CA2207028A1 (fr)
CZ (1) CZ175397A3 (fr)
FI (1) FI972383A0 (fr)
FR (1) FR2727629A1 (fr)
HU (1) HUT77382A (fr)
IL (1) IL116168A0 (fr)
MA (1) MA23737A1 (fr)
NO (1) NO972558L (fr)
PL (1) PL320564A1 (fr)
SK (1) SK68597A3 (fr)
TR (1) TR199501530A1 (fr)
WO (1) WO1996017616A1 (fr)
ZA (1) ZA9510184B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
PT1506041E (pt) 2002-05-10 2007-12-28 Hoffmann La Roche Ácido ibandrónico para o tratamento e a prevenção da osteoporose
SI1790347T1 (sl) * 2002-12-20 2015-03-31 F. Hoffmann-La Roche Ag Formulacija z visokim odmerkom ibandronata

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
ATE161423T1 (de) * 1992-06-30 1998-01-15 Procter & Gamble Pharma Verwendung von phosphinate zur behandlung der osteoporose
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ZA9510184B (en) 1996-06-11
FI972383A (fi) 1997-06-05
NO972558D0 (no) 1997-06-05
PL320564A1 (en) 1997-10-13
CA2207028A1 (fr) 1996-06-13
WO1996017616A1 (fr) 1996-06-13
BR9509961A (pt) 1997-11-25
MA23737A1 (fr) 1996-07-01
CZ175397A3 (en) 1997-10-15
HUT77382A (hu) 1998-04-28
AR002946A1 (es) 1998-05-27
MX9704105A (es) 1997-09-30
AU4307396A (en) 1996-06-26
SK68597A3 (en) 1997-11-05
NO972558L (no) 1997-08-05
JPH10509729A (ja) 1998-09-22
IL116168A0 (en) 1996-01-31
FI972383A0 (fi) 1997-06-05
EP0797444A1 (fr) 1997-10-01
FR2727629B1 (fr) 1997-02-28
FR2727629A1 (fr) 1996-06-07
TR199501530A1 (tr) 1996-10-21
KR980700083A (ko) 1998-03-30

Similar Documents

Publication Publication Date Title
DE69726879T2 (de) Biphosphonat-formulierung mit brausewirkung
EP1416919A1 (fr) Formes posologiques pour la liberation gastrique immediate d'un stimulateur de transport du calcium et la liberation gastrique retardee d'un bis-phosphonate
RU2008103617A (ru) Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза
US4861590A (en) Sustained release fluoride and calcium composition
US5432200A (en) Method for increasing urinary excretion of electrolytes
RU2007103306A (ru) Композиции на основе ризедроната и способы их применения
WO2004058235A2 (fr) Methode pouvant augmenter la biodisponibilite d'alendronate ou autre diphosphonate par administration d'une predose d'un derive de la vitamine d
US4564614A (en) Antiinflammatory methods
CN1168634A (zh) 用于骨质疏松症疗程的试剂盒
CA2671727C (fr) Composition contenant un acide bisphosphonique combine a de la vitamine d
EP1021087A1 (fr) Procede d'elaboration d'une preparation orale contenant de la serotonine, et methodes d'utilisation associees
US5773429A (en) Drug combination for treating calcium loss
CA2219354A1 (fr) Prevention des pertes de dnets par l'administration d'alendronate ou de ses sels
AU628544B2 (en) Dietary supplementation with potassium magnesium citrate
CN101125147B (zh) 氨基葡萄糖钙的药物制剂、制备方法及其应用
WO2000021534A1 (fr) Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine
EP0426098B1 (fr) Agent liant de phosphate pour l'administration orale
EP1661575A1 (fr) Utilisation de magnésium dans le traitement des troubles associés aux variations hormonales chez la femme
WO2005074944A1 (fr) Utilisation de neridronate de sodium pour favoriser une nouvelle formation osseuse
JP2000229853A (ja) 生理痛改善用組成物
MXPA97004105A (en) Set for use in a therapeutic treatment cycle of osteoporo
KR19990056903A (ko) 입덧 치료제
WO1994009790A1 (fr) Application de l'inositolphosphate a la preparation de medicaments
AU2014215992A1 (en) A composition containing a bisphosphonic acid in combination with vitamin D
EP2944315A1 (fr) Méthode et produit pour accélérer la consolidation des fractures osseuses

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication